Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase

OBJECTIVE: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of antidiabetic drugs. They inactivate incretin hormones but also have many other effects throughout the body, among which are effects on the immune system. This might result in an increased infection risk. This study assessed the...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Willemen, Marjolein J., Mantel-Teeuwisse, Aukje K., Straus, Sabine M., Meyboom, Ron H., Egberts, Toine C., Leufkens, Hubert G.
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2011
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3024351/
https://ncbi.nlm.nih.gov/pubmed/21270195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc10-1771
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki